Insider Stock Trading History of Orbimed Capital Ii Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Orbimed Capital Ii Llc since year 2005. The trader's CIK number is 1281668. At the time of this reporting, Orbimed Capital Ii Llc is the Director of Supernus Pharmaceuticals Inc . (stock ticker symbol SUPN). See this page for all insider trading activities at Supernus Pharmaceuticals Inc .

Note that in the past ORBIMED CAPITAL II LLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Orbimed Capital Ii Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-02-13 SUPN Supernus Pharmaceuticals Inc Sale 150,000 7.58 1,136,400
2013-02-12 SUPN Supernus Pharmaceuticals Inc Sale 152,183 7.52 1,144,720
2012-12-18 SUPN Supernus Pharmaceuticals Inc Sale 100,000 7.08 707,700
2012-12-17 SUPN Supernus Pharmaceuticals Inc Sale 197,815 6.85 1,354,637
2006-05-31 AVN Avanir Pharmaceuticals Sale 629,121 9.79 6,159,094
2006-05-24 GIVN Given Imaging Ltd Sale 22,500 18.14 408,150

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Ii Llc (Director of Supernus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.